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Background/aim: Panton–Valentine leukocidin (PVL)-positive methicillin-resistant Staphylococcus aureus (MRSA) infections are
increasing in some regions of Iran. The aim of the current study was to assess the epidemiology and molecular characteristics of S.
aureus isolated from patients with skin infections in Shiraz, Iran.
Materials and methods: Swab samples were obtained from patients admitted to the skin and burn units of hospitals. The medical records
of each patient were collected via questionnaire. All staphylococcal isolates were collected and examined by conventional methods for
detecting S. aureus strains. PCR was used to detect S. aureus harboring the mecA and pvl genes.
Results: Out of 243 staphylococcal isolates, 55 (22.6%) S. aureus and 91 (37.4%) S. epidermidis were detected. Of the 45 patients, 21
(46.7%) were S. aureus carriers. The mecA gene was identified in 60% of S. aureus isolates, and the rest were sensitive to methicillin. Of
the S. aureus isolates, 54.5% were positive for the pvl gene.
Conclusion: This study revealed a high prevalence of PVL-positive MRSA strains in the evaluated hospitals. Thus, early diagnosis of
infections caused by this pathogen seems to be necessary by intake screening allowing for proper treatment, especially in high-risk
patients and in order to prevent the spread of infection.
Key words: Methicillin-resistant S. aureus, methicillin-sensitive S. aureus, Panton–Valentine leukocidin, skin infection, Shiraz, Iran

1. Introduction
Among staphylococcal species, Staphylococcus aureus
has been shown as a clinically relevant human pathogen,
and in many individuals it may lead to asymptomatic
colonization (1). Various infections from skin and soft
tissue infections (SSTIs) to life-threatening infections
like endovascular infections, pneumonia, septic arthritis,
endocarditis, osteomyelitis, and sepsis are caused by
this bacterium (2). Carriage of S. aureus is a risk factor
for subsequent infection in various settings. Recent
investigations suggest that nares-only screening may
underestimate the prevalence of S. aureus colonization,
and accurate determination requires sampling from other
body sites (3). The spread of antibiotic resistance among
strains of S. aureus has been dramatically elevated, such
that methicillin-resistant S. aureus (MRSA) is recognized
as a nosocomial pathogen worldwide. MRSA strains were
once exclusively limited to hospital care; however, after
outbreaks of infection in hospitals and health care facilities
* Correspondence: mhaghkha@shirazu.ac.ir
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they have increasingly been detected among patients in the
community who lack conventional risk factors for MRSA
infection (4). MRSA represents a significant cause of
morbidity and mortality in both hospital and community
settings, which raises serious concerns in the treatment of
staphylococcal infections; hence, the accurate and early
determination of methicillin resistance is a necessity for the
prognosis of S. aureus infections (5). Most MRSA and some
methicillin-susceptible S. aureus (MSSA) isolates produce
Panton–Valentine leukocidin (PVL), a pore-forming toxin
consisting of two subunits S (LukE) and F (LukD) (6,7). It
has become increasingly important as a virulence factor in
necrotizing SSTIs such as furuncle and pneumonia (6). Both
MSSA and community-associated MRSA can express PVL
(8). Contrary to European countries (9), PVL-associated
infections are increasing in some regions of Iran (10). This
study aimed to assess the microbiological, epidemiological,
and clinical features of purulent skin infections caused by
S. aureus in Shiraz, southern Iran.
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2. Materials and methods
2.1. Sampling and isolation
This was a prospective case-control study involving
a convenience sample of inpatients and outpatients
presenting with skin infections. The patients were
hospitalized in the skin and burn units of academic
hospitals or were outpatients referred to the dermatology
department of the Shahid-Faghihi teaching clinic in
Shiraz, Iran. Patients presenting with active infections at
the time of consultation who met the inclusion criteria
for infections were included in the study. Infections
included in this study were diagnosed as surgical site
infections, burn wound infections, pemphigus, ecthyma,
psoriasis, and urticaria with the signs of boils, cellulitis,
abscess, necrosis, and other infections. Swab samples were
obtained from purulent skin lesions requiring incision
and drainage or with spontaneously draining purulent
fluid from 45 patients admitted from September 2013 to
January 2014. In order to detect S. aureus carriers, swabs
were also taken from four other regions (nose, axilla,
umbilicus, and groin). The medical records of all patients
were reviewed and information including age, sex, referral
reason, underlying disease persistence, anatomical site of
infection, clinical symptoms, and previous institutional
admission with household history of similar symptoms
were collected as well in a questionnaire.
All samples were transferred to the microbiology
laboratory in brain heart broth and streaked on blood
agar and MacConkey agar plates. Colonies suspected
as staphylococci were Gram-stained and subcultured
on mannitol salt agar. Collectively, 262 staphylococci
isolates were obtained and stored for further experiments.
Afterwards, S. aureus and S. epidermidis were diagnosed
by biochemical tests including catalase, oxidase, slide and
tube coagulase, mannitol fermentation, DNase, urease,
and VP tests (11).

2.2. DNA extraction
All S. aureus isolates were cultured on blood agar and
incubated overnight at 37 °C. DNA was isolated from the
reference strains with a DNA extraction kit (CinnaGen,
Iran) according to the manufacturer’s instructions.
Obtained DNA was used as the template in all polymerase
chain reactions (PCRs), which are described as follows.
2.3. Polymerase chain reactions
S. aureus isolates were genetically confirmed by speciesspecific PCR (12) and all S. aureus isolates were screened
for the presence of mecA and pvl genes by PCR, as
previously described (6,13). PCR targets, primers used,
and sizes of PCR products are summarized in Table 1.
For species confirmation, DNA amplification was
carried out on a thermocycler (miniMJ model, Bio-Rad,
USA) in a reaction volume of 25 µL, containing 2.5 µL
of 10X PCR buffer (500 mM KCl and Tris HCl, pH 8.4)
(CinnaGen), 1.25 µL of 50 mM MgCl2 (CinnaGen),
0.2 mM of each deoxynucleotide triphosphate (dNTP)
(CinnaGen), 0.25 U of Taq DNA polymerase (CinnaGen),
25 pmol of each primer (CinnaGen), and 5 µL of template
DNA (30 ng/µL). After initial denaturation at 94 °C
for 3 min, PCR products were amplified by 35 cycles of
denaturation at 94 °C for 45 s, annealing at 58.5 °C for 45
s, and extension at 72 °C for 2 min, with a final extension
step at 72 °C for 10 min.
For amplification of the mecA and pvl genes, PCR
cycles were run under the following conditions: initial
DNA denaturation at 95 °C for 7 min, which was followed
by 30 cycles of DNA denaturation at 95 °C for 1 min,
primer annealing at 55 °C for 1 min, and DNA extension
at 72 °C for 1 min. After the final cycle, the reaction was
terminated by keeping it at 72 °C for 7 min for the mecA
gene and DNA denaturation at 92 °C for 30 s, primer
annealing at 58.5 °C for 30 s, and DNA extension at 72 °C
for 45 s with final extension at 72 °C for 10 min for the pvl
gene. Staphylococcus aureus strain NCTC 13300 was used
as a positive control and negative controls contained all
reagents except template DNA.

Table 1. The primer sequences and expected amplicon sizes of each gene investigated by PCR in this study.
Gene name
23S rRNA
mecA
pvl

Primer name

Sequence

Sau327

5’-GGACGACATTAGACGAATCA-3’

Sau1645

5’-CGGGCACCTATTTTCTATCT-3’

mecA-F

5’-CTCAGGTACTGCTATCCACC-3’

mecA-R

5’-CACTTGGATTATCTTCACC-3’

pvl-F

5’-ATCATTAGGTAAAATGTCTGCACATGATCCA-3’

pvl-R

5’-GCATCAACTGTATTGGATAGCCAAAAGC-3’

Amplicon size
(bp)

Reference

1300

Esmailnezhad et al.,
2012 (12)

449

Shitto et al.,
2006 (13)

433

Khosravi et al.,
2012 (6)
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2.4. Detection of PCR products
The PCR products were resolved by electrophoresis
through a 1.5% agarose gel containing ethidium bromide.
2.5. Statistical analysis
The data were analyzed using SPSS 16 (SPSS Inc., Chicago,
IL, USA). The chi-square (χ2) test or Fisher’s exact test was
used to compare categorical variables in all cases and P
< 0.05 was considered statistically significant in the final
model.
3. Results
A total of 409 bacteria were isolated from specimens of
45 patients and 243 of these were Staphylococcus species.
Staphylococci isolates consisted of 55 (22.6%) S. aureus, 91
(37.4%) Staphylococcus epidermidis, and 97 (39.9%) other
staphylococci species (Table 2). S. aureus was the cause of
skin infection in 53.3% of the patients and 24 (53.3%) of
the 45 patients were colonized exclusively by S. aureus. The
relation between sampling site and staphylococcal species
was significant (P < 0.05), as given in Table 3.

By use of specialized primers, the standard S. aureus
NCTC 13300 yielded PCR products of 1300 bp, 449 bp, and
433 bp as expected for the 23S rRNA, mecA, and pvl genes,
respectively, as shown in Figures 1–3. Among the 55 S. aureus
isolates, 30 (54.5%) were PVL-positive and 33 (60%) were
confirmed as MRSA. Epidemiologically, 16 (66.7%) and
18 (75%) patients out of 24 S. aureus carriers had S. aureus
isolates harboring the mecA and pvl genes, respectively. pvl
and mecA positivity was higher in S. aureus carriers (P <
0.001). The pvl gene was detected in 20 (66.7%) MRSA and
10 (33.3%) MSSA isolates (P < 0.001). The prevalence of
pvl in S. aureus strains isolated from burn-injury cases and
patients with skin infection was 53.3% (16/55 S. aureus) and
46.7% (14/55 S. aureus), respectively. PVL-positive S. aureus
was detected in 12.5% (1/8) outpatients and 45.9% (17/37)
inpatients. Demographic characteristics of the patients
included the study and their relationships with S .aureus are
given in Table 4, while Table 5 compares the percentages
of MRSA and PVL-positive S. aureus cases from different
sampling regions.

Table 2. Distribution of organisms isolated from patients with skin infections.
Organism

No. (%) of isolates (n = 409)

S. aureus

55 (22.6%)

MRSA

33 (8.07%)

MSSA

22 (5.38%)

S. epidermidis

91 (22.25%)

Aerobic gram-negative bacilli

60 (14.67%)

a

Non-aureus and -epidermidis species of Staphylococcus

97 (23.71%)

Other

106 (25.92%)

MRSA: Methicillin-resistant Staphylococcus aureus; MSSA, methicillin-susceptible S. aureus.
Pure or mixed with organisms other than Staphylococcus spp, including Pseudomonas aeruginosa,
Enterobacter species, Serratia species, Proteus species, and Escherichia coli.

a

Table 3. Distribution of Staphylococcus species in different samples obtained to detect carriage.
Staphylococcus

Total
n (%)

Sampling region

S. aureus
n (%)

S. epidermidis
n (%)

Other species
n (%)

Lesion

13 (33.3%)

10 (25.6%)

16 (41.0%)

39 (100.0%)

Nose

15 (26.3%)

29 (50.9%)

13 (22.8%)

57 (100.0%)

Axilla

4 (7.1%)

25 (44.6%)

27 (48.2%)

56 (100.0%)

Umbilicus

11 (22.0%)

18 (36.0%)

21 (42.0%)

50 (100.0%)

Groin

12 (29.3%)

9 (22.0%)

20 (48.8%)

41 (100.0%)
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Figure 1. Gel electrophoresis of species-specific 23S rRNA gene
PCR for S. aureus. Lanes: M, 100-bp molecular weight marker;
Lanes 1 and 2, clinical S. aureus isolates; Lane 3, positive control;
Lane 4, negative control.

Figure 2. Gel electrophoresis of mecA gene PCR. Lanes: M, 100bp molecular size marker; 1–5, clinical samples, 1 and 2 mecApositive and 3–5 mecA-negative; 6, positive control; 7, negative
control.

Figure 3. Gel electrophoresis of pvl gene PCR. Lanes: M, 100bp molecular size marker; 1–4, clinical samples, 1–3 pvl-positive
and 4 pvl-negative; 5, positive control; 6, negative control.

The most prevalent lesions among patients were
ulcers (n = 20), necrosis (n = 18), scaly plaque/crust (n =
15), and abscess (n = 5). Significant positive association
was observed between S. aureus infection and necrosis
in skin lesions: 54.2% of S. aureus infections caused
necrotic lesions, and 50% of those were detected as PVLpositive MRSA. S. aureus infections were more common
in patients who used antibiotics (68.9% versus 31.1%).
However, antibiotic exposure did not show significant
association with S. aureus infections and colonization (P
> 0.05). S. aureus infection and carriage rates were higher
in men compared to women (62.5% versus 37.5% for S.
aureus infections and 66.7% versus 33.3% for S. aureus
carriage, P < 0.05). Among patients hospitalized in burn
units, S. aureus infection was detected in 73.7%; this rate
was significantly higher than in other patients with skin

infections (P < 0.05). Surprisingly, none of the infections
in surgical wounds were caused by S. aureus.
4. Discussion
S. aureus is a frequent cause of nosocomial infection. This
bacterium is simply acquired and has the potential to
become resistant to many commonly used antibiotics; the
prevalence of resistant strains is posing serious therapeutic
and infection control problems within the hospital
environment (6). MRSA remains the predominant cause
of acute purulent skin and soft tissue infections. Therefore,
accurate and early detection of methicillin resistance has
an important role in the prognosis of infections caused
by S. aureus (14). Identification of the mecA gene is the
most reliable method to identify MRSA carriers early in
their hospitalization. This allows the prompt initiation of
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Table 4. Comparison of demographic characteristics in patients with skin infections due to S. aureus or other organisms.
Characteristic
Male sex
Referral reason

S. aureus skin infection
group (n = 24)

Non-S. aureus skin infection
group (n = 21)

OR

95% CI

P value

15

7

3.57

0.90–14.72

0.05
0.016

-

a

Burn infection

14

5

4.48

1.05–20.27

0.01

Purulent skin infection

10

12

0.48

0.12–1.87

0.23

Surgical site infection

0

4

0

0–1.27

0.011

14

5

0.82

0.19–3.48

0.76

Comorbidity
Lesion type

…

Pustule

6

8

0.54

0.12–2.31

0.34

Abscess

3

2

1.36

0.16–13.29

0.75

Ulcer

11

9

1.13

0.29–4.34

0.84

Plaque

9

6

1.5

0.36–6.35

0.53

Necrosis

13

5

3.78

0.89–16.93

0.038

Antibiotic therapy

17

14

1.21

0.29–5.16

0.76

Erythromycin

4

3

1.2

0.19–8.04

0.83

Clindamycin

2

3

0.55

0.06–4.7

0.53

Vancomycin

11

4

3.6

0.79–17.52

0.055

Cephalosporins

12

11

0.91

0.24–3.45

0.87

Data are no. of patients. Statistically significant relationships are bolded.
MRSA: Methicillin-resistant S. aureus; PVL: Panton–Valentine leukocidin; MSSA: methicillin-sensitive S. aureus; OR: odds ratio;
CI: confidence interval.
a
Variable significant in multivariable analysis
Table 5. The percentage of MRSA and PVL-positive S. aureus based on sampling regions.

Sampling region

S. aureus
MRSA

PVL-positive S. aureus

Lesion

6 (46.2%)

8 (61.5%)

Nose

8 (53.3%)

6 (40.0%)

Axilla

3 (75.0%)

2 (50.0%)

Umbilicus

9 (81.8%)

5 (45.5%)

Groin

7 (58.3%)

9 (75.0%)

isolation measures to minimize MRSA transmission to
other patients and health care providers (15).
In this study, 33 of the 55 (60%) S. aureus specimens
isolated from skin infections were mecA-positive by PCR.
The prevalence of MRSA was higher in our study compared
to similar studies from Turkey (31.81%) (16), Beijing (3%)
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(17), Egypt (47.37%) (18), and Sao Paulo (10.6%) (15). It
was similar to the rate reported from Torrance, California
(66.57%) (3), and lower than the rate found in a general
report from the United States (79%) (19).
Although there is high geographic variability in the
prevalence of MRSA from different regions of Iran, such
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as 36% (20), 53% (21), 60% (22), 87.36% (6), and 90% (23),
it should be noted that the MRSA strains of the mentioned
reports were isolated from other clinical complications
than skin infections. In terms of frequency, our findings
indicate a greater difference compared to a previous study
in Shiraz (43%) (24). Seasonal changes, which have a
direct relation with bacterial colonization and genetic
changes of S. aureus over time, may also affect the spread
of methicillin resistance among S. aureus strains. In the
present study, the MRSA isolation rate was substantially
higher in S. aureus carriers compared to the isolation rate
from skin lesions (P < 0.001). These varieties may reflect
different policies for infection control and other factors
involved in these areas (25).
In this study, 30 of the 55 (54.5%) S. aureus isolates were
PVL-positive. Miller et al.(3) in Torrance, California, also
reported high PVL positivity (76%) in S. aureus causing
SSTIs. However, other reports employing the same criteria
showed lower prevalences of 15.1%, 15.79%, and 41.46%
in Brazil, Egypt, and China, respectively (15,17,18).
Although our results of pvl gene positivity among S. aureus
strains is in concordance with the findings of Momtaz and
Hafezi (46.34%) (10), it should be considered that a lower
prevalence of pvl was observed in other reports from Iran
(6,26–28). This difference might be due to the fact that
PVL-positive S. aureus isolates are more prevalent in
cutaneous and pulmonary isolates (7), while the sampling
population in the mentioned studies was not limited to
patients with SSTIs. Another reason might be the type of
assay used for detecting the gene. The majority of MRSA
isolates (66.7%) in our study harbored the pvl gene (P <
0.001). This finding is in agreement with the results of
Talan et al. from the United States (19).
Given our finding of a strong association between
S. aureus skin infections and necrotic lesions when
compared to other skin infections caused by other
organisms, it is distinctly possible that lesions infected
with S. aureus are prone to become necrotic. Therefore,
these kinds of lesions need more care and appropriate
medical treatment. The rate of S. aureus infection was
significantly higher in patients hospitalized in burn units
than patients diagnosed with skin infections (P < 0.05).
Hence, targeted intervention measures including hand
hygiene, isolation procedures, cleaning of the hospital
environment, screening, and decolonization of patients
are required to reduce the MRSA acquisition rate in burninjury hospitals. It is interesting that no surgical wound
infection caused by S. aureus was observed. This might
be due to the appropriate control of S. aureus elimination
or the use of broad-spectrum postoperative antibiotics.
The incidence of S. aureus infection in patients receiving
vancomycin showed a considerable decrease with a P-value
of 0.055 (P > 0.05).

We assessed four body sites other than skin lesions for
S. aureus colonization and undertook an epidemiologic
survey in comparison with other studies performed in Iran
(6,29). Our investigation showed a significant association
between sampling sites and isolated staphylococci (P =
0.004). Among the 243 specimens of Staphylococcus species
isolated in this study, the most common were nasal and
axillary samples with a rate of 46.5% (113 isolates). S.
aureus and S. epidermidis were most commonly isolated
from nasal specimens. Colonization of S. aureus in patients
was very common (46.8%) and higher than in those
studies that cited prevalences of 20%–35% in only nasal
colonization (29,30,31). In our study, and similar to other
reports (3), additional anatomic sites were assessed for S.
aureus colonization. Results might have been more reliable
if oropharyngeal samples had also been collected. However,
the yields of these additional sites might be low (3).
We failed to determine a significant association
between antibiotic exposure and S. aureus colonization
(P > 0.05), although the S. aureus colonization rates were
higher in patients with a history of antibiotic use. Our
finding is in accordance with a report of Miller et al. in
the United States (3) that assessed a significant number
of criteria as hypothesized MRSA risk factors and did
not find any relation between MRSA colonization and
antibiotic exposure (P = 0.18).
There are limitations to our study that are going to
be considered in future studies. First, we lacked reliable
data on previous history of skin infection or treatment
for burn patients. Although this was an important risk
factor for S. aureus colonization, such data could not be
obtained reliably and were excluded from our survey.
Second, we failed to include some other risk factors in
our questionnaire such as the history of any contact with
animals or the history of any skin disease in other family
members and last referral time to hospitals for any reason.
Third, our population may not represent other populations
in Iran. It is probably a matter of the geographical variation
that affects the S. aureus genetic profile. Strain typing
could be included with other aims of this study in order to
express more aspects of skin infections caused by S. aureus.
In conclusion, this study provides baseline information
on the epidemiology and molecular characteristics of
S. aureus isolated from patients with skin infections in
Shiraz, southern Iran. Apart from the high prevalence
of MRSA isolates in our study, the considerable rate of
pvl gene positivity is a matter of concern. Since there is
strong evidence of involvement of the pvl gene in the
pathogenesis of S. aureus infections, early determination
of PVL-positive MRSA during hospitalization by intake
screening in high-risk patients will prevent transmission
of infection and also necessitates some control strategies
for decolonization of carriers in hospitals.
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